Hims & Hers Health is set to acquire European telehealth platform Zava, aiming to expand its services across Europe. The deal promises to add 1.3 million customers and enhance access to affordable medications in Ireland, France, and Germany.
Elon Musk has publicly denied recent allegations from the New York Times about his alleged extensive use of ketamine, clarifying that he only tried it once for mental health reasons.
Heartburn affects many, especially as we age. Learn simple lifestyle changes and effective medications to manage and prevent this common discomfort!
From dramatic weight loss transformations to cautionary tales, celebrities are opening up about their experiences with Ozempic and Mounjaro. Discover their honest opinions and the health risks they faced!
Recent clinical trials show that GLP-1 weight loss medications like Zepbound are more effective for women than men, prompting researchers to explore the biological and societal reasons behind this phenomenon.
In a surprising move, Lars Fruergaard Jørgensen is stepping down as CEO of Novo Nordisk after years of leading the company through a successful phase in obesity and diabetes medications. As the search for his successor begins, what does this mean for the future of the pharmaceutical giant?
Spring is here, but so are allergies! Discover effective treatments, from OTC medications to natural remedies, to help you breathe easy and enjoy the season without distress.
Allergy season is getting worse due to climate change, with pollen seasons lasting 20 days longer than in 1990. Discover effective tips and treatments to manage your seasonal allergies this year!
In a groundbreaking move, President Trump has issued an executive order aimed at ending the price discrimination faced by American consumers in the pharmaceutical market. This order seeks to ensure that Americans pay the same low prices for medications as those in other developed nations, addressing the long-standing issue of subsidizing global pharmaceutical profits.
President Trump signs an executive order reviving the 'most favored nation' policy to slash drug costs by linking U.S. prices to lower prices abroad. Will this finally bring relief to American patients?
